Marked eosinophilic response to combined chlorpromazine and trifluoperazine therapy.
D000328:Adult; D002746:Chlorpromazine / Q000009:adverse effects*; D004802:Eosinophilia / Q000139:chemically induced*; D005260:Female; D006801:Humans; D014268:Trifluoperazine / Q000009:adverse effects*
D014268:Trifluoperazine; D002746:Chlorpromazine